News
BLGO
0.182
-0.98%
-0.002
Weekly Report: what happened at BLGO last week (1208-1212)?
Weekly Report · 6d ago
Weekly Report: what happened at BLGO last week (1201-1205)?
Weekly Report · 12/08 09:34
Weekly Report: what happened at BLGO last week (1124-1128)?
Weekly Report · 12/01 09:32
Weekly Report: what happened at BLGO last week (1117-1121)?
Weekly Report · 11/24 09:34
BioLargo Inc. to Present at NobleCon's 21st Annual Emerging Growth Equity Conference
Reuters · 11/21 17:26
BioLargo Officers Convert Salary to Common Stock
TipRanks · 11/18 11:31
BioLargo Officers Convert $99,901 in Debt to Equity at $0.16 Per Share
Reuters · 11/18 11:02
BioLargo’s Earnings Call: Balancing Innovation and Challenges
TipRanks · 11/18 00:04
Weekly Report: what happened at BLGO last week (1110-1114)?
Weekly Report · 11/17 09:35
BioLargo reports Q3 results
Seeking Alpha · 11/17 08:02
BioLargo Inc. reports Q3 revenue of $1.21 million and cash balance of $4.5 million
Reuters · 11/17 08:00
BioLargo Reports Q3 2025 Financial Results Amid Challenges
TipRanks · 11/15 04:02
BioLargo to Present Investor Webcast on Nov 14
TipRanks · 11/14 22:22
BioLargo’s Clyra Medical forms alliance with Advanced Solution
TipRanks · 11/13 13:45
BioLargo Inc. to Report Q3 2025 Earnings Results
Reuters · 11/13 13:30
BioLargo Subsidiary Clyra Signs Exclusive Nationwide Distribution Agreement for ViaCLYR Wound Solution
Reuters · 11/13 13:00
BioLargo files federal lawsuit against Pooph
TipRanks · 11/12 13:30
BioLargo Sues Pooph for Patent Infringement and Fraud
Reuters · 11/12 13:00
Weekly Report: what happened at BLGO last week (1103-1107)?
Weekly Report · 11/10 09:34
BioLargo announces upgrade to Aqueous Electrostatic Concentrator system
TipRanks · 11/03 14:26
More
Webull provides a variety of real-time BLGO stock news. You can receive the latest news about Biolargo through multiple platforms. This information may help you make smarter investment decisions.
About BLGO
BioLargo, Inc. is a cleantech and life sciences innovator and engineering services solution provider. The Company’s core products address polyfluoroalkyl substances (PFAS) contamination, achieve advanced water and wastewater treatment, control odor and VOCs. The Company operates in distinct business segments, including ONM Environmental, which manufactures and sells its odor and VOC control products and services, including its flagship product, CupriDyne Clean; BLEST, which provides professional engineering services; Clyra Medical, which develops and sells medical products based on its technology; BETI, which develops its battery technology; BEST, which sells equipment based on its technology; BioLargo Canada, located in Edmonton, Alberta, Canada, has its primary research and development activities; and corporate operations, which support the operating segments with legal, accounting, human resources, and other services.